NCT03069976View on ClinicalTrials.gov

"Overlap Syndrome and PSC: Evaluating Role of Gut Microflora and Its Identification With Antibiotics in Children"

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

August 31, 2021

Study Completion Date

August 31, 2021

Conditions
Primary Sclerosing CholangitisAutoimmune HepatitisOverlap Syndrome
Interventions
DRUG

Metronidazole

Flagyl x 14 days.

Trial Locations (1)

1200

Cliniques Universitaires Saint-Luc - Université Catholique de Louvain, Brussels

All Listed Sponsors
lead

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER

NCT03069976 - "Overlap Syndrome and PSC: Evaluating Role of Gut Microflora and Its Identification With Antibiotics in Children" | Biotech Hunter | Biotech Hunter